Collegium Pharmaceutical, Inc. (COLL) vs Cronos Group Inc. (CRON)
- Collegium Pharmaceutical, Inc. COLL 23.19 +0.04%
- Cronos Group Inc. CRON 3.22 +0.63%
Collegium Pharmaceutical, Inc. and Cronos Group Inc. are both Drug Manufacturers Specialty & Generic companies. Cronos Group Inc. is the larger, with a market value of $1.2B against $754.6M — 1.6× the size. Collegium Pharmaceutical, Inc. trades at the lower P/E: 15.2× against 16.1×. Cronos Group Inc. grew revenue faster over the last twelve months: 37.5% against 14.3%. Cronos Group Inc. has the higher net margin (20.9% vs 5.93%) and the lower return on invested capital (−0.34% vs 7.85%). Across the 21 metrics below, Collegium Pharmaceutical, Inc. leads on 13 and Cronos Group Inc. on 8.
Valuation
Profitability
| Metric | COLL | CRON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.02% | 45.86% | 53.94% |
| Operating margin | 19.48% | (0.96%) | 0.00% |
| Net margin | 5.93% | 20.91% | 0.00% |
| Free cash flow margin | 40.62% | 27.61% | 0.00% |
| Return on equity | 17.61% | 3.33% | (0.40%) |
| Return on assets | 2.57% | 3.18% | (3.32%) |
| Return on invested capital | 7.85% | (0.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack